Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness
Maged Abdelnaseer1, Nervana Elfayomi1, Eman H Esmail2
1Neurology Department, Cairo University, 49 Misr Hilwan Elzraai Street, Maadi, Cairo, 2218, Egypt.
Abstract:
Atherosclerosis causes significant morbidity and mortality. Carotid intima media thickness (IMT) predicts future ischaemic strok e incidence. Matrix metalloproteinases (MMPs) play a considerable role in atherosclerosis and hold therapeutic promise as well. To investigate the relationship between serum level of matrix metalloproteinase-9 (MMP-9) and common carotid artery intima media thickness (CCA-IMT) in patients with ischaemic stroke and asymptomatic subjects. Thirty patients with a previous ischaemic stroke and 30 asymptomatic volunteers were recruited. Assessment of vascular risk factors, serum level of MMP-9 and CCA-IMT on both sides was performed. The IMT of both CCAs correlated positively with the serum MMP-9 level in asymptomatic subjects (p = 0.000), even after adjustment for other risk factors. In the patients group, this positive correlation was significant for the right but not for the left CCA (right CCA: p = 0.023, left CCA: p = 0.0284). Fasting blood sugar correlated positively with serum levels of MMP-9 in asymptomatic subjects (p = 0.005) but did not correlate positively in patients. There was no significant correlation between MMP-9 and age or other investigated laboratory risk factors in either the patient or asymptomatic groups. MMP-9 is positively correlated with CCA-IMT both in stroke patients and asymptomatic subjects. This may indicate that MMP-9 is a possible therapeutic target for stroke prevention.
Insights
Matrix metalloproteinase-9 (MMP-9) serum levels correlate with carotid intima-media thickness (IMT) in stroke patients and asymptomatic individuals. This suggests MMP-9 may be a therapeutic target for preventing strokes.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Biochemistry
Background:
- Atherosclerosis is a major cause of death and disability.
- Carotid intima-media thickness (IMT) is a predictor of ischemic stroke.
- Matrix metalloproteinases (MMPs), particularly MMP-9, are implicated in atherosclerosis and represent potential therapeutic targets.
Purpose of the Study:
- To investigate the relationship between serum matrix metalloproteinase-9 (MMP-9) levels and common carotid artery intima-media thickness (CCA-IMT).
- To compare this relationship in patients with ischemic stroke versus asymptomatic subjects.
Main Methods:
- Recruited 30 ischemic stroke patients and 30 asymptomatic volunteers.
- Assessed vascular risk factors, serum MMP-9 levels, and bilateral CCA-IMT.
- Analyzed correlations between serum MMP-9 and CCA-IMT, adjusting for risk factors.
Main Results:
- A significant positive correlation was found between CCA-IMT and serum MMP-9 in asymptomatic subjects (p=0.000).
- This correlation was significant for the right CCA (p=0.023) but not the left (p=0.0284) in stroke patients.
- Fasting blood sugar correlated with MMP-9 in asymptomatic subjects (p=0.005) but not in patients. No correlation with age or other risk factors was observed.
Conclusions:
- Serum MMP-9 is positively correlated with CCA-IMT in both stroke patients and asymptomatic individuals.
- MMP-9 may serve as a potential biomarker and therapeutic target for stroke prevention strategies.

